BRIEF published on 06/23/2026 at 14:10, 2 months 25 days ago The Vanguard Group Discloses Position in Beazley plc Form 8.3 Takeover Code Vanguard Group Share Disclosure Beazley Plc
PRESS RELEASE published on 06/23/2026 at 14:08, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.69% stake in Schroders plc as of 22 June 2026. Details in Form 8.3 filing Form 8.3 Schroders Plc Vanguard Group Financial Disclosure Stake Disclosure
PRESS RELEASE published on 06/23/2026 at 14:06, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Forward Industries Inc. The Vanguard Group, Inc. discloses a 3.59% stake in Forward Industries Inc. through ownership of 2,648,393 ordinary shares. Deals include purchasing 329,906 shares and selling 378 shares at $4.27 USD per share Ordinary Shares The Vanguard Group Ownership Stake Forward Industries Inc. $4.27 USD
PRESS RELEASE published on 06/23/2026 at 14:05, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 4.97% interest in Beazley plc. Details of positions and dealings are provided in Form 8.3 Form 8.3 The Vanguard Group Interests Disclosures Beazley Plc
BRIEF published on 06/22/2026 at 15:38, 2 months 25 days ago Vanguard Declares Position in Tate & Lyle plc Securities Disclosure Takeover Code Vanguard Tate & Lyle
BRIEF published on 06/22/2026 at 15:37, 2 months 25 days ago The Vanguard Group Disclosure on Spire Healthcare Holdings Form 8.3 Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
BRIEF published on 06/22/2026 at 15:36, 2 months 25 days ago The Vanguard Group Discloses Position in Schroders plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Schroders Plc
BRIEF published on 06/22/2026 at 15:35, 2 months 25 days ago The Vanguard Group Discloses Position in JTC plc Takeover Code Securities Disclosure Vanguard Group Shareholding JTC Plc
PRESS RELEASE published on 06/22/2026 at 15:33, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses 4.73% ownership in Tate & Lyle plc. Transactions include purchase and sale of 29 1/6p ordinary shares Transactions Shares Vanguard Group Ownership Disclosure Tate & Lyle Plc
BRIEF published on 06/22/2026 at 15:33, 2 months 25 days ago The Vanguard Group Discloses Position in International Personal Finance plc Form 8.3 Disclosure The Vanguard Group Takeover Code International Personal Finance
Published on 09/18/2026 at 14:30, 19 minutes ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/18/2026 at 13:30, 1 hour 19 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 8 hours 19 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 13 hours 54 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 14:25, 23 minutes ago Huawei Unveils Innovative Immersive Telepresence Solution That Offers Immersive Experiences and Intelligent Services
Published on 09/18/2026 at 13:52, 57 minutes ago New rules for green claims. Does eco-friendly also mean animal-friendly?
Published on 09/18/2026 at 13:51, 57 minutes ago Completion of the Acquisition of a Majority Stake in Jucari Global Pty Ltd
Published on 09/18/2026 at 13:50, 58 minutes ago Omio expands premium overnight travel options with Twiliner
Published on 09/18/2026 at 13:30, 1 hour 19 minutes ago EQS-Adhoc: Sibanye Gold Limited: Notice to Bondholders
Published on 09/17/2026 at 17:40, 21 hours 9 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 21 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 7 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
